Search results
Results from the WOW.Com Content Network
On November 8, 2016, Arkansas voters approved Issue 6, the Arkansas Medical Marijuana Amendment, [9] to legalize the medical use of cannabis. [10] [11] A separate measure, the Arkansas Medical Cannabis Act (Issue 7), [12] was disqualified from the ballot 12 days before the election by the Arkansas Supreme Court. [13] [14]
The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. The drug or other substance has a currently accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
Even though hemp-derived products were federally legalized six years ago, products like delta-8 can still show up as marijuana on standard drug tests.
Timeline of Gallup polls in US on legalizing marijuana. [1]In the United States, cannabis is legal in 39 of 50 states for medical use and 24 states for recreational use. At the federal level, cannabis is classified as a Schedule I drug under the Controlled Substances Act, determined to have a high potential for abuse and no accepted medical use, prohibiting its use for any purpose. [2]
In 1995, Partnership for a Drug-Free America with support from the National Institute on Drug Abuse (NIDA) and the White House Office of Drug Control Policy launched a campaign against cannabis use citing a Center on Addiction and Substance Abuse (CASA) report, which claimed that cannabis users are 85 times more likely than non-cannabis users ...
The changes range from limiting the number of retail dispensaries in the state to allowing medical cannabis patients to grow twice as many marijuana plants as other adults. Here's a look at five ...
The Drug Enforcement Administration (DEA) is gearing up to reclassify marijuana in the US as a less dangerous drug, according to new reports, and cannabis company CEOs say the move has been a long ...
Hemp Industries Association v. Drug Enforcement Administration, often shortened to HIA v. DEA, refers to two lawsuits concerning the legality of cannabis extracts and other products from the hemp plant that have very low or nonexistent natural THC levels, including CBD oil, in the United States. The first is from 2004 and the second is from 2018.